Contract awardedRadioisotopes

Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo)

Supply of Xofigo (radium-223 dichloride) for use in nuclear medicine prostate cancer treatment pathways. This is a direct procurement of a specific pharmaceutical product for a two-year period, ensuring continuity of supply for clinical patient care.

Awarded value
£106k
As published
Published
19 March 2026
Awarded
31 December 2025
Bayer
Contract length
24 months
Ends 30 December 2027

What the contract covers

Purchase and supply of pharmaceutical product

Supply and delivery of specialist radiopharmaceutical products for the clinical treatment of prostate cancer within NHS nuclear medicine departments.

  • Purchase Xofigo for radiopharmaceutical treatment of prostate cancer in Nuclear Medicine

Terms and requirements

Contract type
Purchase and supply of pharmaceutical product
Procedure
Direct award
Initial term
24 months
Contract dates
31 December 2025 to 30 December 2027
Certifications asked for
None stated
Lots
1
Suitable for SMEs
Not stated
CPV codes
33000000

Services in this contract

Lifecycle

  1. Published
  2. Contract awardedto Bayer
  3. Contract starts
  4. Contract ends
The buyer

United Lincolnshire Teaching Hospitals NHS Trust

Type
Locked
Contracts, 24 months
Locked
Recorded value
Locked
Typical contract
Locked
Radioisotopes contracts, 24 months
Locked
Buys mostLocked
Contact details
Name
Locked
Email
Locked
Website
Locked
Address
Locked
See everything United Lincolnshire Teaching Hospitals NHS Trust buys
The supplier

Bayer

Contracts won, 24 months
Locked
Value won, 24 months
Locked
Buyers, 24 months
Locked
Size
Locked
Companies House number
Locked
Main buyersLocked
Contact details
Email
Locked
See everything Bayer has won

Similar radioisotopes contracts and prices

6 radioisotopes contracts were awarded in the East Midlands in the last 24 months. See who won them and what they went for, next to this one.

See who won them →

Cite this contract

Link
https://bidskim.com/tender/355311/radiopharmaceuticals-treatment-of-prostate-cancer-xofigo
Buyer reference
C422573
Open contracting ID
ocds-h6vhtk-066f3b
Last checked
5 November 2026

United Lincolnshire Teaching Hospitals NHS Trust. Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo). Contract award, 19 March 2026. BidSkim, https://bidskim.com/tender/355311/radiopharmaceuticals-treatment-of-prostate-cancer-xofigo (accessed 5 November 2026).